Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapy SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leader in AI-powered disease ...
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91%. While colonoscopy remains the gold ...
Researchers at Michigan State University created an insect brain-based gas sensing platform to detect lung cancer cell lines. With more development, the technology could be used to detect cancer and ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback